TRPV4 and neoplasm: Notably, tumor vasculature in TRPV4 KO mice presented a greater percentage of hyper-permeable, pericyte-free and dilated microvessels (Adapala et al., 2016), which are known to temper the therapeutic outcome of anticancer treatments (Moccia, 2018).